Compare TLPH & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLPH | ZENV |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 58.9M |
| IPO Year | 2011 | 2021 |
| Metric | TLPH | ZENV |
|---|---|---|
| Price | $1.00 | $0.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 475.9K | 25.6K |
| Earning Date | 11-12-2025 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $28,000.00 | ★ $201,426,369.00 |
| Revenue This Year | N/A | $12.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.80 |
| 52 Week Low | $0.38 | $0.87 |
| 52 Week High | $1.57 | $2.74 |
| Indicator | TLPH | ZENV |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 28.66 |
| Support Level | $0.97 | $0.88 |
| Resistance Level | $1.07 | $1.00 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 9.37 | 9.75 |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.